GlaxoSmithKline and Sanofi’s Covid-19 vaccine saw strong results from its phase 2 trial and will now move on to a larger phase 3 trial as the drugs firms try to catch up with the competition.
Interim results from the study show a 95% to 100% seroconversion following a second injection in patients from ages 18 to 95, with no safety concerns raised.
Bosses added there was a high immune response after a single dose, as they hope the vaccine could be used as part of any booster programme for later in the year.
READ MORE: Covid in Scotland: Majority of Scotland eases into Level 2 - but how does it compare with rest of UK?
The UK Government has said that booster shots could be given out later this year or early in 2022, although no decision has been made on who could receive the extra jabs and when.
GSK hopes to muscle in on the Covid-19 vaccine market (Andy Buchanan/PA)
World Health Organisation officials have called on wealthier nations to ensure poorer countries have access to initial vaccination programmes before administering their own booster initiatives.
Sanofi and GSK added there are also trials and research ongoing to see whether vaccines made by different companies can be mixed in patients.
Those who received the pharmaceutical brands’ vaccine showed strong neutralising antibody levels compared with those who received a placebo in the study across 722 volunteers.
READ MORE: Scots cases of Indian Covid variant ‘of concern’ quadruple in a week
The phase 3 study will kick off “in the coming weeks”, bosses said, and they pointed out their vaccine could be stored at normal temperatures.
Thomas Triomphe, executive vice president at Sanofi, said: “Our phase 2 data confirm the potential of this vaccine to play a role in addressing this ongoing global public health crisis, as we know multiple vaccines will be needed, especially as variants continue to emerge and the need for effective and booster vaccines, which can be stored at normal temperatures, increases.”
Roger Connor, president of GSK Vaccines, said: “We believe that this vaccine candidate can make a significant contribution to the ongoing fight against Covid-19 and will move to phase 3 as soon as possible to meet our goal of making it available before the end of the year.”
The phase 3 trial will involve 35,000 volunteers and look at the effectiveness against the Wuhan and South African variants.
Bosses added that they intend to conduct booster studies with various variant formulations to assess the ability of a lower dose of the vaccine to generate a strong booster response regardless of the initial vaccine platform received.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here